Reliv International, Inc. announced that Dr. Alfredo Galvez has been appointed as the company's Chief Scientific Advisor. Galvez has been associated with Reliv since 2013 and is best known for his groundbreaking work with lunasin. He currently holds 10 issued and two pending US patents on the lunasin technology. Dr. Galvez is currently developing new product lines that will combine the power of lunasin and hemp extract.